Date: 2015-02-05
Type of information: Grant
Company: Plasticell (UK)
Investors: Innovate UK (UK)
Amount: £1.3 million
Funding type: grant
Planned used: The grant will support a research consortium led by Plasticell for a project entitled ‘Ex-vivo expansion of cord blood and bone marrow stem cells”. The consortium includes the University of Oxford and the Cell Therapy Catapult. This therapeutic programme will use CombiCult®, Plasticell\'s high throughput stem cell technology, to solve bottlenecks in regenerative medicine development. Using CombiCult®, Plasticell has tested millions of combinations of cell culture components to develop cord blood expansion media which amplify stem cells by up to 100-fold. This grant will allow the consortium to develop a clinically compliant process to expand cord blood stem cells ex vivo using Plasticell’s media, allowing more patients to be treated with this life-saving therapy.
Others: * On February 5, 2015, Plasticell has announced that Innovate UK has made a further investment in a therapeutic programme utilising CombiCult®, the high throughput stem cell technology designed to solve bottlenecks in regenerative medicine development Innovate UK will provide a grant of approximately £1.3 million to a research consortium led by Plasticell for a project entitled ‘Ex-vivo expansion of cord blood and bone marrow stem cells”.
Therapeutic area: Technology - Services - Regenerative medicine
